We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alphabet (Google) Class A
GOOGL
$4.37T
| $11.2M | 0.25% |
292,960
+19,400
| +7% | +$714K |
|
|
VER
77
DELISTED
VEREIT, Inc.
VER
| $11M | 0.25% |
248,324
-13,110
| -5% | -$520K |
|
78
Amazon
AMZN
$3T
| $10.8M | 0.24% |
363,760
+33,740
| +10% | +$958K |
|
79
Intel
INTC
$492B
| $10.7M | 0.24% |
332,061
+15,684
| +5% | +$481K |
|
80
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $10.6M | 0.24% |
88,877
-61,932
| -41% | -$7.12M |
|
81
Philip Morris
PM
$290B
| $10.4M | 0.24% |
106,176
+10,334
| +11% | +$948K |
|
82
State Street Health Care Select Sector SPDR ETF
XLV
$44B
| $10.3M | 0.23% |
151,777
-27,849
| -16% | -$1.87M |
|
83
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $10.1M | 0.23% |
99,490
+9,430
| +10% | +$888K |
|
84
iShares S&P 500 Growth ETF
IVW
$77.4B
| $10.1M | 0.23% |
348,424
-28,544
| -8% | -$785K |
|
85
Visa
V
$675B
| $10.1M | 0.23% |
131,889
+20,862
| +19% | +$1.52M |
|
86
Vanguard FTSE Europe ETF
VGK
$31B
| $10.1M | 0.23% |
207,221
-1,064
| -0.5% | -$49.8K |
|
87
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $9.96M | 0.23% |
117,101
+17,186
| +17% | +$1.46M |
|
88
WisdomTree International SmallCap Dividend Fund
DLS
$1.07B
| $9.92M | 0.22% |
168,467
+7,765
| +5% | +$429K |
|
89
Ford
F
$55.8B
| $9.89M | 0.22% |
732,651
+16,139
| +2% | +$203K |
|
90
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $9.81M | 0.22% |
323,732
+38,876
| +14% | +$1.1M |
|
91
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
| $9.63M | 0.22% |
105,402
+100,709
| +2,146% | +$9.2M |
|
92
Bristol-Myers Squibb
BMY
$132B
| $9.59M | 0.22% |
150,153
-327
| -0.2% | -$20.6K |
|
93
Gilead Sciences
GILD
$165B
| $9.59M | 0.22% |
104,414
+2,557
| +3% | +$231K |
|
94
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $9.53M | 0.22% |
155,639
+148,708
| +2,146% | +$9.08M |
|
95
State Street SPDR S&P Dividend ETF
SDY
$22.1B
| $9.49M | 0.21% |
118,743
+5,011
| +4% | +$371K |
|
96
Bank of America
BAC
$447B
| $9.24M | 0.21% |
683,663
+4,177
| +0.6% | +$56.4K |
|
97
Cisco
CSCO
$483B
| $9.15M | 0.21% |
321,418
+4,524
| +1% | +$116K |
|
98
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
| $9.01M | 0.2% |
135,651
+23,408
| +21% | +$1.49M |
|
99
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $8.95M | 0.2% |
261,236
+43,607
| +20% | +$1.35M |
|
100
Merck
MRK
$323B
| $8.94M | 0.2% |
177,029
+3,415
| +2% | +$167K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.